ARVAC-A

· Centro de Educación Medica e Investigaciones Clinicas Norberto Quirno

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ARVAC-A, covering 2023-12-22 to 2023-12-22. Get the full timeline:

Most recent: Clinical Trial Update: ARVAC-A New Recombinant Coronavirus Disease 2019 (COVID-19) Vaccine [Phase 2, Phase 3]